Middle East And Africa Epilepsy Monitoring Devices Market
حجم السوق بالمليار دولار أمريكي
CAGR :
% 
 فترة التنبؤ |
2024 –2030 |
 حجم السوق (السنة الأساسية) |
|
 حجم السوق (سنة التنبؤ) |
USD 42.13 |
 CAGR |
% |
| Major Markets Players |
سوق أجهزة مراقبة الصرع في الشرق الأوسط وأفريقيا، حسب نوع المنتج (الأجهزة القابلة للارتداء، والأجهزة الذكية، والأجهزة التقليدية)، النوع (النوبات البؤرية، والنوبات المعممة)، نوع المريض (الأطفال، وكبار السن، والبالغين)، المستخدم النهائي (المستشفيات، وإعدادات الرعاية المنزلية، ومراكز الأعصاب، ومراكز التشخيص، ومراكز وعيادات الجراحة الخارجية ، وغيرها)، قناة التوزيع (مبيعات التجزئة، والمبيعات عبر الإنترنت، والعطاءات المباشرة، وغيرها) - اتجاهات الصناعة والتوقعات حتى عام 2030.
تحليل حجم سوق أجهزة مراقبة الصرع في الشرق الأوسط وأفريقيا
يساعد الطلب المتزايد على أجهزة مراقبة الصرع القابلة للارتداء في تعزيز النمو الإجمالي للسوق. كما تساهم الاستثمارات الحكومية المتزايدة في مشاريع الصرع في نمو السوق. يركز اللاعبون الرئيسيون في السوق بشكل كبير على تطوير أجهزة مراقبة الصرع الجديدة المختلفة. بالإضافة إلى ذلك، يساهم انتشار الصرع المتزايد أيضًا في زيادة الطلب على السوق.
من المتوقع أن يحقق سوق أجهزة مراقبة الصرع في الشرق الأوسط وأفريقيا نموًا في السوق في الفترة المتوقعة من 2023 إلى 2030. تحلل شركة Data Bridge Market Research أن السوق ينمو بمعدل نمو سنوي مركب قدره 5.3٪ في الفترة المتوقعة من 2023 إلى 2030 ومن المتوقع أن يصل إلى 42.13 مليون دولار أمريكي بحلول عام 2030.
|
تقرير القياس |
تفاصيل |
|
فترة التنبؤ |
2023 إلى 2030 |
|
سنة الأساس |
2022 |
|
سنة تاريخية |
2021 (قابلة للتخصيص حتى 2020-2015) |
|
وحدات كمية |
الإيرادات بالملايين من الدولارات الأمريكية |
|
القطاعات المغطاة |
حسب نوع المنتج ( الأجهزة القابلة للارتداء ، والأجهزة الذكية، والأجهزة التقليدية)، والنوع (النوبات البؤرية، والنوبات العامة)، ونوع المريض (الأطفال، وكبار السن، والبالغين)، والمستخدم النهائي (المستشفيات، وإعدادات الرعاية المنزلية، ومراكز الأعصاب، ومراكز التشخيص، ومراكز وعيادات الجراحة الخارجية، وغيرها)، وقناة التوزيع (مبيعات التجزئة، والمبيعات عبر الإنترنت، والعطاءات المباشرة، وغيرها) |
|
الدول المغطاة |
جنوب أفريقيا، الإمارات العربية المتحدة، مصر، المملكة العربية السعودية، الكويت، إسرائيل، البحرين، عمان، قطر، بقية دول الشرق الأوسط وأفريقيا |
|
الجهات الفاعلة في السوق المشمولة |
شركة NIHON KOHDEN CORPORATION.، وMasimo، وApple Inc.، وNatus Medical Incorporated.، وOwlet، وNeurotech, LLC، وSmartMonitor، وEpilert، وغيرها. |
تعريف السوق
الصرع هو اضطراب يصيب الجهاز العصبي المركزي (العصبي) حيث يصبح نشاط المخ غير طبيعي، مما يسبب نوبات أو فترات من السلوك غير المعتاد والأحاسيس وأحيانًا فقدان الوعي. يمكن أن تتراوح النوبات الصرعية من فترات قصيرة وغير قابلة للاكتشاف تقريبًا إلى فترات طويلة من الارتعاش الشديد بسبب النشاط الكهربائي غير الطبيعي في المخ. النوع الأكثر شيوعًا من النوبات هو التشنجات، والتي تنطوي على تقلصات عضلية لا إرادية.
تحدث النوبات التوترية الرمعية مع تقلص الأطراف متبوعًا بتمديدها وانحناء الظهر، والتي تستمر من 10 إلى 30 ثانية. تتضمن النوبات الرمعية تقلصات قصيرة جدًا للعضلات إما في مناطق قليلة أو في جميع أنحاء الجسم.
Middle East & Africa Epilepsy Monitoring Devices Market Dynamics
Drivers
-
Rising prevalence of epilepsy
Epilepsy is a neurological condition that causes unprovoked, recurrent seizures. A seizure is a sudden rush of abnormal electrical activity in the brain. Doctors diagnose epilepsy when someone has two or more seizures with no other identifiable cause. Anyone can develop epilepsy, but it most commonly onsets in young and older adults. A mild seizure may be difficult to recognize. It may only last a few seconds, and the individual may remain awake while it happens. Stronger seizures can cause spasms and uncontrollable muscle twitches. They can last from a few seconds to several minutes and may cause confusion or loss of consciousness. Afterward, the individual may have no memory of a seizure happening.
Epilepsy has become the world’s most common neurological disorder among every age group. As epilepsy can be treated if diagnosed early, people with epilepsy symptoms are more focused on its diagnosis & treatment by using various technologically advanced monitoring devices. As a result, the demand for epilepsy monitoring devices is increasing & hence, the rising prevalence of epilepsy is driving the growth of the Middle East & Africa epilepsy monitoring devices market.
-
Growing preference for wearable epilepsy monitoring devices
It is a major challenge in clinical epilepsy to diagnose and treat a disease characterized by infrequent seizures based on patient or caregiver reports and limited-duration clinical testing. The poor reliability of self-reported seizure diaries for many people with epilepsy is well-established, but these records remain necessary in clinical care and therapeutic studies.
Several wearable devices have emerged which are capable of detecting seizures, recording seizure data and alerting caregivers. Wearable devices may also facilitate reliable forecasts of seizure likelihood, providing the potential for people with epilepsy to take fast-acting medications or modify activities in anticipation of an impending seizure. Therefore, wearable sensing devices are increasing in popularity both in the general community & through medical applications. Hence, the growing preference for wearable epilepsy monitoring devices is driving the growth of the Middle East & Africa epilepsy monitoring devices market.
-
Rising government investments in the epilepsy project
Epilepsy has become the world’s most common neurological disorder, and so has the mortality rate. Research on the underlying causes of epilepsies, including the identification of genes for some forms of epilepsy, has led to a greatly improved understanding of these disorders that may lead to treatments that are more effective or even to new ways of preventing epilepsy in the future.
Government is more focused on fewer deaths, a better quality of life for patients suffering from epilepsy and fewer seizures. This can be possible with the combination of advanced imaging, cognitive and genetic data, personalized treatment plans and a skilled surgical team where necessary. Hence, the government is investing more in epilepsy projects to enhance the infrastructure and better care for patients. Therefore, it can be a driving factor for the growth of the Middle East & Africa epilepsy monitoring devices market.
Opportunities
-
Rise in technological advancement in the disease monitoring device
With the advent of time, medical devices have undergone various technological changes. The advancement in disease-monitoring medical devices includes using flexible electronics such as thin flaps or skin patches for the accurate and real-time monitoring of vital signs. The validation and accuracy of the recorded data by such devices are also enhanced by the upgradation of new operating software and hardware used in those devices. The advanced flaps-like monitoring system is manufactured by various key market leaders like Neurava, Neuronostics, Epilepsy Alarms and others. Instant and precise assessment of results coupled with the noteworthy existence of these devices due to advancements; escalate the customer preference and adoption rate of such devices. Thus, innovations leading to superior product characteristics and cost-effectivity will spur Middle East & Africa market expansion of epilepsy monitoring devices.
The innovation and advancement in technology have upgraded medical devices in all prospects, including battery life, light weightiness, advanced features like AI assistance, upgraded software, and wireless connectivity, among more. Technological advancement brings many advantages to the patient’s diagnosis and therapeutic uses with improvements in remote monitoring systems. Thus, the increased technological advancement boosts the growth of the Middle East & Africa epilepsy monitoring devices market.
-
Increased demand for the non-invasive and minimally invasive device
An invasive device is a complicated, painful, and risky procedure, as it involves direct intervention with the brain tissue. Therefore, healthcare professionals and patients show a high inclination towards the use of non-invasive and minimally invasive devices. With rising awareness, more patients are opting for minimally invasive or non-invasive procedures. Epilepsy monitoring devices overcome the risks and pain associated with invasive brain monitoring. Many government initiatives also focus on reducing the risks related to treatment options for brain disorders.
Restraints/Challenges
- Poor reimbursement scenario
Reimbursement for all healthcare devices and services has been under downward pressure for several years. These devices also face a major roadblock in their growth due to the lack of reimbursement of these devices. The combination of wearable devices with AI, irrelevant data collection and security issues of medical devices pose a significant impact on these devices that leads to difficulty in a gain of reimbursement for such devices. The reimbursement of a device can significantly affect the ability of a provider to access a particular technology, as well as the willingness of a manufacturer to deliver it. If coverage is uncertain, the manufacturer has difficulty predicting whether an investment in new technology will yield enough returns. This lack of predictability is an apparent barrier to obtaining funding for the company. It further compromises innovation and restricts patient access to advanced technology and solutions.
Monitoring devices have become an important part of healthcare in terms of diagnosis and prognosis of chronic diseases. The increased application of monitoring devices in conditions like neurological, diabetes, obesity and cardiovascular issues, among more, makes it crucial for the healthcare facility. However, the high cost of such devices and the lack of proper reimbursement hampers the adoption rate of these medical devices. Thus, the lack of reimbursement acts as a challenge to the growth of the Middle East & Africa epilepsy monitoring market.
Post-COVID-19 Impact on Middle East & Africa Molecular Diagnostics Services Market
The post-COVID-19 has negatively affected the market. A large number of the population were affected by this pandemic. The supply of ophthalmic products has suffered a massive hit due to the Middle East & Africa pandemic of COVID-19. This reduction in supply is mainly due to various quarantine policies adopted by countries worldwide. This, along with the restrictions of movement and labor reduction, are the major reasons for a decreasing trend in the supply market of medical devices. This has affected the quality and efficacy of medical devices to a high extent. Reduction in the headcount of the labor force due to COVID-19 affliction is another factor contributing to the reduced supply of epilepsy monitoring devices.
Recent Developments
- In December 2022, NIHON KOHDEN CORPORATION announced that it would open a new sale branch of Nihon Kohden Singapore (NKS), one of its sales subsidiaries, aiming to apply for registration of medical devices smoothly and expand its sales in the Philippines
- في فبراير 2022، أعلنت شركة ماسيمو عن دخولها في اتفاقية اندماج نهائية للاستحواذ على شركة فايبر هولدينجز كوربوريشن، التي تمتلك شركة ساوند يونايتد ("ساوند يونايتد"). تمتلك شركة التكنولوجيا الاستهلاكية هذه مجموعة من العلامات التجارية المتميزة، بما في ذلك باورز آند ويلكنز، ودينون، وبولك أوديو، ومارانتز. وبموجب اتفاقية الاندماج، كان عليهم دفع ما يقرب من 1.025 مليار دولار أمريكي، مع مراعاة التعديلات، مقابل الاستحواذ. وهذا يساعد المنظمة على توليد المزيد من الإيرادات
نطاق سوق أجهزة مراقبة الصرع في الشرق الأوسط وأفريقيا
يتم تقسيم سوق أجهزة مراقبة الصرع في الشرق الأوسط وأفريقيا إلى خمسة قطاعات بارزة بناءً على نوع المنتج والنوع ونوع المريض والمستخدم النهائي وقناة التوزيع. سيساعدك النمو بين هذه القطاعات على تحليل قطاعات النمو الضئيلة في الصناعات وتزويد المستخدمين بنظرة عامة قيمة على السوق ورؤى السوق لاتخاذ قرارات استراتيجية لتحديد تطبيقات السوق الأساسية.
حسب نوع المنتج
- الأجهزة القابلة للارتداء
- الأجهزة الذكية
- الأجهزة التقليدية
على أساس نوع المنتج، يتم تقسيم السوق إلى أجهزة قابلة للارتداء وأجهزة ذكية وأجهزة تقليدية.
حسب النوع
- النوبات البؤرية
- النوبات المعممة
على أساس النوع، يتم تقسيم السوق إلى نوبات بؤرية ونوبات معممة.
حسب نوع المريض
- طب الأطفال
- كبار السن
- البالغون
على أساس نوع المريض، يتم تقسيم السوق إلى طب الأطفال وطب الشيخوخة والبالغين.
حسب المستخدم النهائي
- المستشفيات
- إعداد الرعاية المنزلية
- مراكز طب الأعصاب
- مراكز التشخيص
- مراكز وعيادات الجراحة الخارجية
- آحرون
على أساس المستخدمين النهائيين، يتم تقسيم السوق إلى المستشفيات، ومؤسسات الرعاية المنزلية، ومراكز الأعصاب، ومراكز التشخيص، ومراكز العيادات الجراحية الخارجية وغيرها.
حسب قناة التوزيع
- مبيعات التجزئة
- المبيعات عبر الإنترنت
- العطاءات المباشرة
- آحرون
على أساس قناة التوزيع، يتم تقسيم السوق إلى مبيعات التجزئة، والمبيعات عبر الإنترنت، والعطاءات المباشرة وغيرها.
تحليل/رؤى إقليمية لسوق أجهزة مراقبة الصرع في الشرق الأوسط وأفريقيا
يتم تحليل سوق أجهزة مراقبة الصرع في الشرق الأوسط وأفريقيا، ويتم توفير رؤى حجم السوق والاتجاهات حسب البلد ونوع المنتج والنوع ونوع المريض والمستخدم النهائي وقناة التوزيع.
الدول التي تغطيها سوق أجهزة مراقبة الصرع في الشرق الأوسط وأفريقيا هي جنوب أفريقيا والإمارات العربية المتحدة ومصر والمملكة العربية السعودية والكويت وإسرائيل والبحرين وعمان وقطر وبقية دول الشرق الأوسط وأفريقيا.
تهيمن جنوب إفريقيا على سوق أجهزة مراقبة الصرع في الشرق الأوسط وأفريقيا بسبب زيادة عدد اللاعبين في السوق وتوافر أجهزة مراقبة الصرع المتقدمة المختلفة في السوق. إلى جانب ذلك، زاد عدد التعاونات الحكومية والخاصة في السوق، مما يعزز نمو السوق بشكل أكبر. ومع ذلك، فإن التكلفة العالية المرتبطة بأجهزة وإجراءات مراقبة الصرع المعقدة قد تعيق نمو السوق في فترة التوقعات.
كما يوفر قسم الدولة في التقرير عوامل فردية مؤثرة على السوق والتغييرات في اللوائح في السوق محليًا والتي تؤثر على الاتجاهات الحالية والمستقبلية للسوق. تعد نقاط البيانات مثل المبيعات الجديدة ومبيعات الاستبدال والتركيبة السكانية للدولة وعلم الأوبئة المرضية ورسوم الاستيراد والتصدير من بين المؤشرات الرئيسية المستخدمة للتنبؤ بسيناريو السوق للدول الفردية. كما يتم النظر في وجود وتوافر العلامات التجارية العالمية والتحديات التي تواجهها بسبب المنافسة الكبيرة أو النادرة من العلامات التجارية المحلية والمحلية التي تؤثر على قنوات المبيعات أثناء تقديم تحليل توقعات لبيانات الدولة.
تحليل المنافسة وحصة سوق أجهزة مراقبة الصرع في الشرق الأوسط وأفريقيا
يقدم المشهد التنافسي لسوق أجهزة مراقبة الصرع في الشرق الأوسط وأفريقيا تفاصيل عن المنافسين. تتضمن التفاصيل نظرة عامة على الشركة، والبيانات المالية للشركة، والإيرادات المولدة، وإمكانات السوق، والاستثمار في البحث والتطوير، والمبادرات الجديدة في السوق، والحضور في الشرق الأوسط وأفريقيا، ومواقع الإنتاج والمرافق، والقدرات الإنتاجية، ونقاط القوة والضعف للشركة، وإطلاق المنتج، وعرض المنتج ونطاقه، وهيمنة التطبيق. تتعلق نقاط البيانات المذكورة أعلاه فقط بتركيز الشركات على السوق.
بعض اللاعبين الرئيسيين العاملين في سوق أجهزة مراقبة الصرع في الشرق الأوسط وأفريقيا هم NIHON KOHDEN CORPORATION.، وMasimo، وApple Inc.، وNatus Medical Incorporated.، وOwlet، وNeurotech، LLC، وSmartMonitor، وEpilert، وغيرها.
SKU-
احصل على إمكانية الوصول عبر الإنترنت إلى التقرير الخاص بأول سحابة استخبارات سوقية في العالم
- لوحة معلومات تحليل البيانات التفاعلية
- لوحة معلومات تحليل الشركة للفرص ذات إمكانات النمو العالية
- إمكانية وصول محلل الأبحاث للتخصيص والاستعلامات
- تحليل المنافسين باستخدام لوحة معلومات تفاعلية
- آخر الأخبار والتحديثات وتحليل الاتجاهات
- استغل قوة تحليل المعايير لتتبع المنافسين بشكل شامل
Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE MIDDLE EAST & AFRICA EPILEPSY MONITORING DEVICES MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MIDDLE EAST & AFRICA EPILEPSY MONITORING DEVICES MARKET: SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 PRODUCT TYPE SEGMENT LIFELINE CURVE
2.8 DBMR MARKET POSITION GRID
2.9 VENDOR SHARE ANALYSIS
2.1 MARKET END USER COVERAGE GRID
2.11 SECONDARY SOURCES
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
PREMIUM INSIGHTS 92
4.1.1 KEY STRATEGIC INITIATIVES
4.1.2 SEIZURES OCCURRENCE, BY TIME
4.1.2.1 DURING DAY
4.1.2.2 DURING SLEEP
4.1.2.2.1 RAPID EYE MOVEMENT (REM) SLEEP
4.1.2.2.2 NON-REM SLEEP
4.1.2.3 DURING NIGHT
5 EPIDEMIOLOGY
5.1 INCIDENCE & PREVALENCE OF EPILEPSY, BY COUNTRY
5.1.1 GENERALIZED SEIZURES, BY PATIENT TYPE
5.1.1.1 TONIC-CLONIC SEIZURES
5.1.1.2 ABSENCE SEIZURES
5.1.2 FOCAL SEIZURES, BY PATIENT TYPE
5.1.2.1 SIMPLE FOCAL SEIZURES
5.1.2.2 COMPLEX FOCAL SEIZURES
5.1.2.3 SECONDARY GENERALIZED SEIZURES
6 MIDDLE EAST & AFRICA EPILEPSY MONITORING DEVICE MARKET, REGULATORY FRAMEWORK
6.1 MEDICAL DEVICES
6.2 WEARABLE MEDICAL DEVICES
7 MARKET OVERVIEW
7.1 DRIVERS
7.1.1 RISING PREVALENCE OF EPILEPSY
7.1.2 GROWING PREFERENCE FOR WEARABLE EPILEPSY MONITORING DEVICES
7.1.3 RISING GOVERNMENT INVESTMENTS IN THE EPILEPSY PROJECT
7.1.4 INCREASED R & D ACTIVITIES IN EPILEPSY
7.2 RESTRAINTS
7.2.1 HIGH COST ASSOCIATED WITH COMPLEX EPILEPSY MONITORING PROCEDURES & DEVICES
7.2.2 PRODUCT RECALL SCENARIO OF EPILEPSY MONITORING DEVICES
7.3 OPPORTUNITIES
7.3.1 RISE IN TECHNOLOGY ADVANCEMENT IN DISEASE MONITORING DEVICE
7.3.2 INCREASED DEMAND FOR NON-INVASIVE AND MINIMALLY INVASIVE DEVICE
7.4 CHALLENGES
7.4.1 POOR REIMBURSEMENT SCENARIO
7.4.2 STRINGENT RULES & REGULATIONS FOR PRODUCT APPROVAL
8 MIDDLE EAST & AFRICA EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE
8.1 OVERVIEW
8.2 WEARABLE DEVICES
8.2.1 SMART WATCHES
8.2.2 OTHER NON-INVASIVE MONITORING DEVICES
8.3 SMART DEVICES
8.3.1 MOTION MONITORS
8.3.2 1.3.2 VIDEO MONITORS
8.3.3 MATTRESS DEVICES
8.3.4 OTHERS
8.4 CONVENTIONAL DEVICES
8.4.1 EEG DEVICE
8.4.1.1 AMBULATORY EEG
8.4.1.2 CONTINUOUS EEG
8.4.1.3 OTHER EEG DEVICES
8.4.2 ELECTROMYOGRAPHY (EMG) DEVICE
8.4.3 ELECTROCARDIOGRAM (ECG) DEVICE
8.4.4 PULSE- OXIMETERS
8.4.5 IMPLANTED ADVISORY SYSTEM
8.4.6 TRIAXIAL ACCELEROMETER (ACM)
8.4.7 MAGNETOMETERS
8.4.8 OTHER DEVICES
9 MIDDLE EAST & AFRICA EPILEPSY MONITORING DEVICES MARKET, BY TYPE
9.1 OVERVIEW
9.2 FOCAL SEIZURES
9.2.1 SIMPLE FOCAL SEIZURES
9.2.1.1 SMART DEVICES
9.2.1.2 WEARABLE DEVICES
9.2.1.3 CONVENTIONAL DEVICES
9.2.2 COMPLEX FOCAL SEIZURES
9.2.2.1 SMART DEVICES
9.2.2.2 WEARABLE DEVICES
9.2.2.3 CONVENTIONAL DEVICES
9.2.3 SECONDARY GENERALIZED SEIZURES
9.2.3.1 SMART DEVICES
9.2.3.2 WEARABLE DEVICES
9.2.3.3 CONVENTIONAL DEVICES
9.3 GENERALIZED SEIZURES
9.3.1 TONIC-CLONIC SEIZURES
9.3.1.1 SMART DEVICES
9.3.1.2 WEARABLE DEVICES
9.3.1.3 CONVENTIONAL DEVICES
9.3.2 ABSENCE SEIZURES
9.3.2.1 SMART DEVICES
9.3.2.2 WEARABLE DEVICES
9.3.2.3 CONVENTIONAL DEVICES
10 MIDDLE EAST & AFRICA EPILEPSY MONITORING DEVICES MARKET, BY PATIENT TYPE
10.1 OVERVIEW
10.2 PEDIATRIC
10.3 GERIATRIC
10.4 ADULTS
11 MIDDLE EAST & AFRICA EPILEPSY MONITORING DEVICES MARKET, BY END USER
11.1 OVERVIEW
11.2 HOSPITALS
11.3 HOMECARE SETTINGS
11.4 NEUROLOGY CENTRES
11.5 DIAGNOSTIC CENTRES
11.6 AMBULATORY SURGICAL CENTRES AND CLINICS
11.7 OTHERS
12 MIDDLE EAST & AFRICA EPILEPSY MONITORING DEVICES MARKET, BY DISTRIBUTION CHANNEL
12.1 OVERVIEW
12.2 RETAIL SALES
12.3 ONLINE SALES
12.4 DIRECT TENDERS
12.5 OTHERS
13 MIDDLE EAST & AFRICA EPILEPSY MONITORING DEVICES MARKET, BY REGION
13.1 MIDDLE EAST AND AFRICA
13.1.1 SOUTH AFRICA
13.1.2 UAE
13.1.3 EGYPT
13.1.4 SAUDI ARABIA
13.1.5 KUWAIT
13.1.6 ISRAEL
13.1.7 BAHRAIN
13.1.8 OMAN
13.1.9 QATAR
13.1.10 REST OF MIDDLE EAST AND AFRICA
14 MIDDLE EAST & AFRICA EPILEPSY MONITORING DEVICES MARKET: COMPANY LANDSCAPE
14.1 COMPANY SHARE ANALYSIS: MIDDLE EAST & AFRICA
15 SWOT
16 COMPANY PROFILES
16.1 NIHON KOHDEN CORPORATION.
16.1.1 COMPANY SNAPSHOT
16.1.2 RECENT FINANCIALS
16.1.3 COMPANY SHARE ANALYSIS
16.1.4 PRODUCT PORTFOLIO
16.1.5 RECENT DEVELOPMENT
16.2 MASIMO
16.2.1 COMPANY SNAPSHOT
16.2.2 RECENT FINANCIALS
16.2.3 COMPANY SHARE ANALYSIS
16.2.4 PRODUCT PORTFOLIO
16.2.5 RECENT DEVELOPMENT
16.3 APPLE INC.
16.3.1 COMPANY SNAPSHOT
16.3.2 REVENUE ANALYSIS
16.3.3 COMPANY SHARE ANALYSIS
16.3.4 PRODUCT PORTFOLIO
16.3.5 RECENT DEVELOPMENTS
16.4 NATUS MEDICAL INCORPORATED.
16.4.1 COMPANY SNAPSHOT
16.4.2 RECENT FINANCIALS
16.4.3 COMPANY SHARE ANALYSIS
16.4.4 PRODUCT PORTFOLIO
16.4.5 RECENT DEVELOPMENT
16.5 OWLET.
16.5.1 COMPANY SNAPSHOT
16.5.2 REVENUE ANALYSIS
16.5.3 COMPANY SHARE ANALYSIS
16.5.4 PRODUCT PORTFOLIO
16.5.5 RECENT DEVELOPMENT
16.6 ACTIGRAPH, LLC.
16.6.1 COMPANY SNAPSHOT
16.6.2 PRODUCT PORTFOLIO
16.6.3 RECENT DEVELOPMENT
16.7 ADVANCED BRAIN MONITORING, INC.
16.7.1 COMPANY SNAPSHOT
16.7.2 PRODUCT PORTFOLIO
16.7.3 RECENT DEVELOPMENT
16.8 CAPTUREPROFF INC.
16.8.1 COMPANY SNAPSHOT
16.8.2 PRODUCT PORTFOLIO
16.8.3 RECENT DEVELOPMENT
16.9 EMPATICA INC.
16.9.1 COMPANY SNAPSHOT
16.9.2 PRODUCT PORTFOLIO
16.9.3 RECENT DEVELOPMENT
16.1 EPIHUNTER
16.10.1 COMPANY SNAPSHOT
16.10.2 PRODUCT PORTFOLIO
16.10.3 RECENT DEVELOPMENT
16.11 EPILERT
16.11.1 COMPANY SNAPSHOT
16.11.2 PRODUCT PORTFOLIO
16.11.3 RECENT DEVELOPMENT
16.12 EPILEPSY ALARMS UK
16.12.1 COMPANY SNAPSHOT
16.12.2 PRODUCT PORTFOLIO
16.12.3 RECENT DEVELOPMENT
16.13 EPI USA.
16.13.1 COMPANY SNAPSHOT
16.13.2 PRODUCT PORTFOLIO
16.13.3 RECENT DEVELOPMENT
16.14 EPIVIEW
16.14.1 COMPANY SNAPSHOT
16.14.2 PRODUCT PORTFOLIO
16.14.3 RECENT DEVELOPMENT
16.15 FREQUENCY PRECISION.
16.15.1 COMPANY SNAPSHOT
16.15.2 PRODUCT PORTFOLIO
16.15.3 RECENT DEVELOPMENT
16.16 HIPASS DESIGN LLC
16.16.1 COMPANY SNAPSHOT
16.16.2 PRODUCT PORTFOLIO
16.16.3 RECENT DEVELOPMENT
16.17 IBABY LABS, INC.
16.17.1 COMPANY SNAPSHOT
16.17.2 PRODUCT PORTFOLIO
16.17.3 RECENT DEVELOPMENT
16.18 ITS DESIGNS LTD
16.18.1 COMPANY SNAPSHOT
16.18.2 PRODUCT PORTFOLIO
16.18.3 RECENT DEVELOPMENT
16.19 LIVASSURED
16.19.1 COMPANY SNAPSHOT
16.19.2 PRODUCT PORTFOLIO
16.19.3 RECENT DEVELOPMENT
16.2 LIVELIFE ALARMS.
16.20.1 COMPANY SNAPSHOT
16.20.2 PRODUCT PORTFOLIO
16.20.3 RECENT DEVELOPMENT
16.21 MEDPAGE LTD
16.21.1 COMPANY SNAPSHOT
16.21.2 PRODUCT PORTFOLIO
16.21.3 RECENT DEVELOPMENT
16.22 MIKU INC.
16.22.1 COMPANY SNAPSHOT
16.22.2 PRODUCT PORTFOLIO
16.22.3 RECENT DEVELOPMENT
16.23 NEUROSOFT
16.23.1 COMPANY SNAPSHOT
16.23.2 PRODUCT PORTFOLIO
16.23.3 RECENT DEVELOPMENTS
16.24 NEUROTECH, LLC
16.24.1 COMPANY SNAPSHOT
16.24.2 PRODUCT PORTFOLIO
16.24.3 RECENT DEVELOPMENT
16.25 SAFE-LIFE
16.25.1 COMPANY SNAPSHOT
16.25.2 PRODUCT PORTFOLIO
16.25.3 RECENT DEVELOPMENT
16.26 SMARTMONITOR
16.26.1 COMPANY SNAPSHOT
16.26.2 PRODUCT PORTFOLIO
16.26.3 RECENT DEVELOPMENT
16.27 SNUZA
16.27.1 COMPANY SNAPSHOT
16.27.2 PRODUCT PORTFOLIO
16.27.3 RECENT DEVELOPMENT
16.28 THE ‘LIFE MINDER’
16.28.1 COMPANY SNAPSHOT
16.28.2 PRODUCT PORTFOLIO
16.28.3 RECENT DEVELOPMENT
16.29 VAHLKAMP INTERNATIONAL B.V.
16.29.1 COMPANY SNAPSHOT
16.29.2 PRODUCT PORTFOLIO
16.29.3 RECENT DEVELOPMENT
17 QUESTIONNAIRE
18 RELATED REPORTS
List of Table
TABLE 1 REGULATORY APPROVAL CONSIDERATIONS IN WEARABLE MEDICAL DEVICES (WMDS)
TABLE 2 REGULATORY APPROVAL CONSIDERATIONS IN WEARABLE MEDICAL DEVICES (WMDS)
TABLE 3 REGULATORY APPROVAL CONSIDERATIONS IN WEARABLE MEDICAL DEVICES (WMDS)
TABLE 4 MIDDLE EAST & AFRICA EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 5 MIDDLE EAST & AFRICA WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 6 MIDDLE EAST & AFRICA WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 7 MIDDLE EAST & AFRICA SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 8 MIDDLE EAST & AFRICA SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 9 MIDDLE EAST & AFRICA CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 10 MIDDLE EAST & AFRICA CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 11 MIDDLE EAST & AFRICA EEG DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 12 MIDDLE EAST & AFRICA EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 13 MIDDLE EAST & AFRICA FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 14 MIDDLE EAST & AFRICA FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 15 MIDDLE EAST & AFRICA SIMPLE FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 16 MIDDLE EAST & AFRICA COMPLEX FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 17 MIDDLE EAST & AFRICA SECONDARY GENERALIZED SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 18 MIDDLE EAST & AFRICA GENERALIZED SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 19 MIDDLE EAST & AFRICA GENERALIZED SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 20 MIDDLE EAST & AFRICA TONIC-CLONIC SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION))
TABLE 21 MIDDLE EAST & AFRICA ABSENCE SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 22 MIDDLE EAST & AFRICA EPILEPSY MONITORING DEVICES MARKET, BY PATIENT TYPE, 2021-2030 (USD MILLION)
TABLE 23 MIDDLE EAST & AFRICA PEDIATRIC IN EPILEPSY MONITORING DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 24 MIDDLE EAST & AFRICA GERIATRIC IN EPILEPSY MONITORING DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 25 MIDDLE EAST & AFRICA ADULTS IN EPILEPSY MONITORING DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 26 MIDDLE EAST & AFRICA EPILEPSY MONITORING DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 27 MIDDLE EAST & AFRICA HOSPITALS IN EPILEPSY MONITORING DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 28 MIDDLE EAST & AFRICA HOMECARE SETTINGS IN EPILEPSY MONITORING DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 29 MIDDLE EAST & AFRICA NEUROLOGY CENTERS IN EPILEPSY MONITORING DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 30 MIDDLE EAST & AFRICA DIAGNOSTIC CENTERS IN EPILEPSY MONITORING DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 31 MIDDLE EAST & AFRICA AMBULATORY SURGICAL CENTRES AND CLINIC IN EPILEPSY MONITORING DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 32 MIDDLE EAST & AFRICA OTHERS IN EPILEPSY MONITORING DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 33 MIDDLE EAST & AFRICA EPILEPSY MONITORING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 34 MIDDLE EAST & AFRICA RETAIL SALES IN EPILEPSY MONITORING DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 35 MIDDLE EAST & AFRICA ONLINE SALES IN EPILEPSY MONITORING DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 36 MIDDLE EAST & AFRICA DIRECT TENDERS IN EPILEPSY MONITORING DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 37 MIDDLE EAST & AFRICA OTHERS IN EPILEPSY MONITORING DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 38 MIDDLE EAST AND AFRICA EPILEPSY MONITORING DEVICES MARKET, BY COUNTRY, 2021-2030 (USD MILLION)
TABLE 39 MIDDLE EAST AND AFRICA EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 40 MIDDLE EAST AND AFRICA WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 41 MIDDLE EAST AND AFRICA WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 42 MIDDLE EAST AND AFRICA WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 43 MIDDLE EAST AND AFRICA SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 44 MIDDLE EAST AND AFRICA SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 45 MIDDLE EAST AND AFRICA SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 46 MIDDLE EAST AND AFRICA CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 47 MIDDLE EAST AND AFRICA CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 48 MIDDLE EAST AND AFRICA CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 49 MIDDLE EAST AND AFRICA EEG DEVICE IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 50 MIDDLE EAST AND AFRICA EEG DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 51 MIDDLE EAST AND AFRICA EEG DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 52 MIDDLE EAST AND AFRICA EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 53 MIDDLE EAST AND AFRICA FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 54 MIDDLE EAST AND AFRICA SIMPLE FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 55 MIDDLE EAST AND AFRICA COMPLEX FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 56 MIDDLE EAST AND AFRICA SECONDARY GENERALIZED SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 57 MIDDLE EAST AND AFRICA GENERALIZED SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 58 MIDDLE EAST AND AFRICA TONIC-CLONIC SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 59 MIDDLE EAST AND AFRICA ABSENCE SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 60 MIDDLE EAST AND AFRICA EPILEPSY MONITORING DEVICES MARKET, BY PATIENT TYPE, 2021-2030 (USD MILLION)
TABLE 61 MIDDLE EAST AND AFRICA EPILEPSY MONITORING DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 62 MIDDLE EAST AND AFRICA EPILEPSY MONITORING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 63 SOUTH AFRICA EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 64 SOUTH AFRICA WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 65 SOUTH AFRICA WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 66 SOUTH AFRICA WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 67 SOUTH AFRICA SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 68 SOUTH AFRICA SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 69 SOUTH AFRICA SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 70 SOUTH AFRICA CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 71 SOUTH AFRICA CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 72 SOUTH AFRICA CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 73 SOUTH AFRICA EEG DEVICE IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 74 SOUTH AFRICA EEG DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 75 SOUTH AFRICA EEG DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 76 SOUTH AFRICA EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 77 SOUTH AFRICA FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 78 SOUTH AFRICA SIMPLE FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 79 SOUTH AFRICA COMPLEX FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 80 SOUTH AFRICA SECONDARY GENERALIZED SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 81 SOUTH AFRICA GENERALIZED SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 82 SOUTH AFRICA TONIC-CLONIC SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 83 SOUTH AFRICA ABSENCE SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 84 SOUTH AFRICA EPILEPSY MONITORING DEVICES MARKET, BY PATIENT TYPE, 2021-2030 (USD MILLION)
TABLE 85 SOUTH AFRICA EPILEPSY MONITORING DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 86 SOUTH AFRICA EPILEPSY MONITORING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 87 U.A.E EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 88 U.A.E WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 89 U.A.E WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 90 U.A.E WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 91 U.A.E SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 92 U.A.E SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 93 U.A.E SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 94 U.A.E CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 95 U.A.E CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 96 U.A.E CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 97 U.A.E EEG DEVICE IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 98 U.A.E EEG DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 99 U.A.E EEG DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 100 U.A.E EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 101 U.A.E FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 102 U.A.E SIMPLE FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 103 U.A.E COMPLEX FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 104 U.A.E SECONDARY GENERALIZED SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 105 U.A.E GENERALIZED SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 106 U.A.E TONIC-CLONIC SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 107 U.A.E ABSENCE SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 108 U.A.E EPILEPSY MONITORING DEVICES MARKET, BY PATIENT TYPE, 2021-2030 (USD MILLION)
TABLE 109 U.A.E EPILEPSY MONITORING DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 110 U.A.E EPILEPSY MONITORING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 111 EGYPT EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 112 EGYPT WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 113 EGYPT WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 114 EGYPT WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 115 EGYPT SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 116 EGYPT SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 117 EGYPT SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 118 EGYPT CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 119 EGYPT CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 120 EGYPT CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 121 EGYPT EEG DEVICE IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 122 EGYPT EEG DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 123 EGYPT EEG DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 124 EGYPT EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 125 EGYPT FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 126 EGYPT SIMPLE FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 127 EGYPT COMPLEX FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 128 EGYPT SECONDARY GENERALIZED SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 129 EGYPT GENERALIZED SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 130 EGYPT TONIC-CLONIC SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 131 EGYPT ABSENCE SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 132 EGYPT EPILEPSY MONITORING DEVICES MARKET, BY PATIENT TYPE, 2021-2030 (USD MILLION)
TABLE 133 EGYPT EPILEPSY MONITORING DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 134 EGYPT EPILEPSY MONITORING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 135 SAUDI ARABIA EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 136 SAUDI ARABIA WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 137 SAUDI ARABIA WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 138 SAUDI ARABIA WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 139 SAUDI ARABIA SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 140 SAUDI ARABIA SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 141 SAUDI ARABIA SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 142 SAUDI ARABIA CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 143 SAUDI ARABIA CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 144 SAUDI ARABIA CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 145 SAUDI ARABIA EEG DEVICE IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 146 SAUDI ARABIA EEG DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 147 SAUDI ARABIA EEG DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 148 SAUDI ARABIA EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 149 SAUDI ARABIA FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 150 SAUDI ARABIA SIMPLE FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 151 SAUDI ARABIA COMPLEX FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 152 SAUDI ARABIA SECONDARY GENERALIZED SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 153 SAUDI ARABIA GENERALIZED SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 154 SAUDI ARABIA TONIC-CLONIC SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 155 SAUDI ARABIA ABSENCE SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 156 SAUDI ARABIA EPILEPSY MONITORING DEVICES MARKET, BY PATIENT TYPE, 2021-2030 (USD MILLION)
TABLE 157 SAUDI ARABIA EPILEPSY MONITORING DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 158 SAUDI ARABIA EPILEPSY MONITORING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 159 KUWAIT EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 160 KUWAIT WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 161 KUWAIT WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 162 KUWAIT WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 163 KUWAIT SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 164 KUWAIT SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 165 KUWAIT SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 166 KUWAIT CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 167 KUWAIT CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 168 KUWAIT CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 169 KUWAIT EEG DEVICE IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 170 KUWAIT EEG DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 171 KUWAIT EEG DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 172 KUWAIT EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 173 KUWAIT FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 174 KUWAIT SIMPLE FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 175 KUWAIT COMPLEX FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 176 KUWAIT SECONDARY GENERALIZED SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 177 KUWAIT GENERALIZED SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 178 KUWAIT TONIC-CLONIC SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 179 KUWAIT ABSENCE SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 180 KUWAIT EPILEPSY MONITORING DEVICES MARKET, BY PATIENT TYPE, 2021-2030 (USD MILLION)
TABLE 181 KUWAIT EPILEPSY MONITORING DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 182 KUWAIT EPILEPSY MONITORING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 183 ISRAEL EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 184 ISRAEL WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 185 ISRAEL WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 186 ISRAEL WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 187 ISRAEL SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 188 ISRAEL SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 189 ISRAEL SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 190 ISRAEL CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 191 ISRAEL CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 192 ISRAEL CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 193 ISRAEL EEG DEVICE IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 194 ISRAEL EEG DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 195 ISRAEL EEG DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 196 ISRAEL EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 197 ISRAEL FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 198 ISRAEL SIMPLE FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 199 ISRAEL COMPLEX FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 200 ISRAEL SECONDARY GENERALIZED SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 201 ISRAEL GENERALIZED SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 202 ISRAEL TONIC-CLONIC SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 203 ISRAEL ABSENCE SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 204 ISRAEL EPILEPSY MONITORING DEVICES MARKET, BY PATIENT TYPE, 2021-2030 (USD MILLION)
TABLE 205 ISRAEL EPILEPSY MONITORING DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 206 ISRAEL EPILEPSY MONITORING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 207 BAHRAIN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 208 BAHRAIN WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 209 BAHRAIN WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 210 BAHRAIN WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 211 BAHRAIN SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 212 BAHRAIN SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 213 BAHRAIN SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 214 BAHRAIN CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 215 BAHRAIN CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 216 BAHRAIN CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 217 BAHRAIN EEG DEVICE IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 218 BAHRAIN EEG DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 219 BAHRAIN EEG DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 220 BAHRAIN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 221 BAHRAIN FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 222 BAHRAIN SIMPLE FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 223 BAHRAIN COMPLEX FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 224 BAHRAIN SECONDARY GENERALIZED SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 225 BAHRAIN GENERALIZED SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 226 BAHRAIN TONIC-CLONIC SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 227 BAHRAIN ABSENCE SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 228 BAHRAIN EPILEPSY MONITORING DEVICES MARKET, BY PATIENT TYPE, 2021-2030 (USD MILLION)
TABLE 229 BAHRAIN EPILEPSY MONITORING DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 230 BAHRAIN EPILEPSY MONITORING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 231 OMAN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 232 OMAN WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 233 OMAN WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 234 OMAN WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 235 OMAN SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 236 OMAN SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 237 OMAN SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 238 OMAN CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 239 OMAN CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 240 OMAN CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 241 OMAN EEG DEVICE IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 242 OMAN EEG DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 243 OMAN EEG DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 244 OMAN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 245 OMAN FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 246 OMAN SIMPLE FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 247 OMAN COMPLEX FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 248 OMAN SECONDARY GENERALIZED SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 249 OMAN GENERALIZED SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 250 OMAN TONIC-CLONIC SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 251 OMAN ABSENCE SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 252 OMAN EPILEPSY MONITORING DEVICES MARKET, BY PATIENT TYPE, 2021-2030 (USD MILLION)
TABLE 253 OMAN EPILEPSY MONITORING DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 254 OMAN EPILEPSY MONITORING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 255 QATAR EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 256 QATAR WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 257 QATAR WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 258 QATAR WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 259 QATAR SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 260 QATAR SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 261 QATAR SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 262 QATAR CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 263 QATAR CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 264 QATAR CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 265 QATAR EEG DEVICE IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 266 QATAR EEG DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 267 QATAR EEG DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 268 QATAR EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 269 QATAR FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 270 QATAR SIMPLE FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 271 QATAR COMPLEX FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 272 QATAR SECONDARY GENERALIZED SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 273 QATAR GENERALIZED SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 274 QATAR TONIC-CLONIC SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 275 QATAR ABSENCE SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 276 QATAR EPILEPSY MONITORING DEVICES MARKET, BY PATIENT TYPE, 2021-2030 (USD MILLION)
TABLE 277 QATAR EPILEPSY MONITORING DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 278 QATAR EPILEPSY MONITORING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 279 REST OF MIDDLE EAST AND AFRICA EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
List of Figure
FIGURE 1 MIDDLE EAST & AFRICA EPILEPSY MONITORING DEVICES MARKET: SEGMENTATION
FIGURE 2 MIDDLE EAST & AFRICA EPILEPSY MONITORING DEVICES MARKET: DATA TRIANGULATION
FIGURE 3 MIDDLE EAST & AFRICA EPILEPSY MONITORING DEVICES MARKET: DROC ANALYSIS
FIGURE 4 MIDDLE EAST & AFRICA EPILEPSY MONITORING DEVICES MARKET: MIDDLE EAST & AFRICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 MIDDLE EAST & AFRICA EPILEPSY MONITORING DEVICES MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 MIDDLE EAST & AFRICA EPILEPSY MONITORING DEVICES MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 MIDDLE EAST & AFRICA EPILEPSY MONITORING DEVICES MARKET: DBMR POSITION GRID
FIGURE 8 MIDDLE EAST & AFRICA EPILEPSY MONITORING DEVICES MARKET: VENDOR SHARE ANALYSIS
FIGURE 9 MIDDLE EAST & AFRICA EPILEPSY MONITORING DEVICES MARKET: END USER COVERAGE GRID
FIGURE 10 MIDDLE EAST & AFRICA EPILEPSY MONITORING DEVICES MARKET: SEGMENTATION
FIGURE 11 THE RISING PREVALENCE OF EPILEPSY & GROWING PREFERENCE FOR WEARABLE EPILEPSY MONITORING DEVICES ARE EXPECTED TO DRIVE THE MIDDLE EAST & AFRICA EPILEPSY MONITORING DEVICES MARKET FROM 2023 TO 2030
FIGURE 12 THE WEARABLE DEVICE SEGMENT IS EXPECTED TO HAVE THE LARGEST SHARE OF THE MIDDLE EAST & AFRICA EPILEPSY MONITORING DEVICES MARKET FROM 2023 TO 2030
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF THE MIDDLE EAST & AFRICA EPILEPSY MONITORING DEVICES MARKET
FIGURE 14 MIDDLE EAST & AFRICA EPILEPSY MONITORING DEVICES MARKET: BY PRODUCT TYPE, 2022
FIGURE 15 MIDDLE EAST & AFRICA EPILEPSY MONITORING DEVICES MARKET: BY PRODUCT TYPE, 2023-2030 (USD MILLION)
FIGURE 16 MIDDLE EAST & AFRICA EPILEPSY MONITORING DEVICES MARKET: BY PRODUCT TYPE, CAGR (2023-2030)
FIGURE 17 MIDDLE EAST & AFRICA EPILEPSY MONITORING DEVICES MARKET : BY PRODUCT TYPE, LIFELINE CURVE
FIGURE 18 MIDDLE EAST & AFRICA EPILEPSY MONITORING DEVICES MARKET: BY TYPE, 2022
FIGURE 19 MIDDLE EAST & AFRICA EPILEPSY MONITORING DEVICES MARKET: BY TYPE, 2023-2030 (USD MILLION)
FIGURE 20 MIDDLE EAST & AFRICA EPILEPSY MONITORING DEVICES MARKET: BY TYPE, CAGR (2023-2030)
FIGURE 21 MIDDLE EAST & AFRICA EPILEPSY MONITORING DEVICES MARKET: BY TYPE, LIFELINE CURVE
FIGURE 22 MIDDLE EAST & AFRICA EPILEPSY MONITORING DEVICES MARKET: BY PATIENT TYPE, 2022
FIGURE 23 MIDDLE EAST & AFRICA EPILEPSY MONITORING DEVICES MARKET: BY PATIENT TYPE 2023-2030 (USD MILLION)
FIGURE 24 MIDDLE EAST & AFRICA EPILEPSY MONITORING DEVICES MARKET: BY PATIENT TYPE, CAGR (2023-2030)
FIGURE 25 MIDDLE EAST & AFRICA EPILEPSY MONITORING DEVICES MARKET: BY PATIENT TYPE, LIFELINE CURVE
FIGURE 26 MIDDLE EAST & AFRICA EPILEPSY MONITORING DEVICES MARKET: BY END USER, 2022
FIGURE 27 MIDDLE EAST & AFRICA EPILEPSY MONITORING DEVICES MARKET: BY END USER, 2023-2030 (USD MILLION)
FIGURE 28 MIDDLE EAST & AFRICA EPILEPSY MONITORING DEVICES MARKET: BY END USER, CAGR (2023-2030)
FIGURE 29 MIDDLE EAST & AFRICA EPILEPSY MONITORING DEVICES MARKET: BY END USER, LIFELINE CURVE
FIGURE 30 MIDDLE EAST & AFRICA EPILEPSY MONITORING DEVICES MARKET: BY DISTRIBUTION CHANNEL, 2022
FIGURE 31 MIDDLE EAST & AFRICA EPILEPSY MONITORING DEVICES MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)
FIGURE 32 MIDDLE EAST & AFRICA EPILEPSY MONITORING DEVICES MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)
FIGURE 33 MIDDLE EAST & AFRICA EPILEPSY MONITORING DEVICES MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 34 MIDDLE EAST AND AFRICA EPILEPSY MONITORING DEVICES MARKET: SNAPSHOT (2022)
FIGURE 35 MIDDLE EAST AND AFRICA EPILEPSY MONITORING DEVICES MARKET: BY COUNTRY (2022)
FIGURE 36 MIDDLE EAST AND AFRICA EPILEPSY MONITORING DEVICES MARKET: BY COUNTRY (2023 & 2030)
FIGURE 37 MIDDLE EAST AND AFRICA EPILEPSY MONITORING DEVICES MARKET: BY COUNTRY (2022 & 2030)
FIGURE 38 MIDDLE EAST AND AFRICA EPILEPSY MONITORING DEVICES MARKET: PRODUCT TYPE (2023-2030)
FIGURE 39 MIDDLE EAST & AFRICA EPILEPSY MONITORING DEVICES MARKET: COMPANY SHARE 2022 (%)
منهجية البحث
يتم جمع البيانات وتحليل سنة الأساس باستخدام وحدات جمع البيانات ذات أحجام العينات الكبيرة. تتضمن المرحلة الحصول على معلومات السوق أو البيانات ذات الصلة من خلال مصادر واستراتيجيات مختلفة. تتضمن فحص وتخطيط جميع البيانات المكتسبة من الماضي مسبقًا. كما تتضمن فحص التناقضات في المعلومات التي شوهدت عبر مصادر المعلومات المختلفة. يتم تحليل بيانات السوق وتقديرها باستخدام نماذج إحصائية ومتماسكة للسوق. كما أن تحليل حصة السوق وتحليل الاتجاهات الرئيسية هي عوامل النجاح الرئيسية في تقرير السوق. لمعرفة المزيد، يرجى طلب مكالمة محلل أو إرسال استفسارك.
منهجية البحث الرئيسية التي يستخدمها فريق بحث DBMR هي التثليث البيانات والتي تتضمن استخراج البيانات وتحليل تأثير متغيرات البيانات على السوق والتحقق الأولي (من قبل خبراء الصناعة). تتضمن نماذج البيانات شبكة تحديد موقف البائعين، وتحليل خط زمني للسوق، ونظرة عامة على السوق ودليل، وشبكة تحديد موقف الشركة، وتحليل براءات الاختراع، وتحليل التسعير، وتحليل حصة الشركة في السوق، ومعايير القياس، وتحليل حصة البائعين على المستوى العالمي مقابل الإقليمي. لمعرفة المزيد عن منهجية البحث، أرسل استفسارًا للتحدث إلى خبراء الصناعة لدينا.
التخصيص متاح
تعد Data Bridge Market Research رائدة في مجال البحوث التكوينية المتقدمة. ونحن نفخر بخدمة عملائنا الحاليين والجدد بالبيانات والتحليلات التي تتطابق مع هدفهم. ويمكن تخصيص التقرير ليشمل تحليل اتجاه الأسعار للعلامات التجارية المستهدفة وفهم السوق في بلدان إضافية (اطلب قائمة البلدان)، وبيانات نتائج التجارب السريرية، ومراجعة الأدبيات، وتحليل السوق المجدد وقاعدة المنتج. ويمكن تحليل تحليل السوق للمنافسين المستهدفين من التحليل القائم على التكنولوجيا إلى استراتيجيات محفظة السوق. ويمكننا إضافة عدد كبير من المنافسين الذين تحتاج إلى بيانات عنهم بالتنسيق وأسلوب البيانات الذي تبحث عنه. ويمكن لفريق المحللين لدينا أيضًا تزويدك بالبيانات في ملفات Excel الخام أو جداول البيانات المحورية (كتاب الحقائق) أو مساعدتك في إنشاء عروض تقديمية من مجموعات البيانات المتوفرة في التقرير.
